Early treatment of high-risk chronic lymphocytic leukemia with alemtuzumab and rituximab-Reference-Cited by-同舟云学术

Early treatment of high-risk chronic lymphocytic leukemia with alemtuzumab and rituximab

Published:2008-10-15 Issue:8 Volume:113 Page:2110-2118
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Zent Clive S.,Call Timothy G.,Shanafelt Tait D.,Tschumper Renee C.,Jelinek Diane F.,Bowen Deborah A.,Secreto Charla R.,LaPlant Betsy R.,Kabat Brian F.,Kay Neil E.

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference30 articles.

1. Incidence of chronic lymphocytic leukemia in Olmsted County, Minnesota, 1935 through 1989, with emphasis on changes in initial stage at diagnosis;Call;Mayo Clin Proc,1994

2. The prognostic significance of cytopenia in chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL);Zent;Br J Haematol,2008

3. When and how to treat chronic lymphocytic leukemia;Dighiero;N Engl J Med,2000

4. Genomic aberrations and survival in chronic lymphocytic leukemia;Dohner;N Engl J Med,2000

5. Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia;Damle;Blood,1999

Cited by 61 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Imprime PGG Enhances Anti-Tumor Effects of Tumor-Targeting, Anti-Angiogenic, and Immune Checkpoint Inhibitor Antibodies;Frontiers in Oncology;2022-05-26

2. Immune Pharmacodynamic Responses of the Novel Cancer Immunotherapeutic Imprime PGG in Healthy Volunteers;The Journal of Immunology;2019-04-15

3. Can early intervention with pharmacotherapy reduce the morbidity and mortality of chronic lymphocytic leukemia?;Expert Opinion on Pharmacotherapy;2018-07-18

4. Treatment of chronic lymphocytic leukemia in older adults;Journal of Geriatric Oncology;2017-09

5. Imprime PGG-Mediated Anti-Cancer Immune Activation Requires Immune Complex Formation;PLOS ONE;2016-11-03